SEPTInvestingStart Free

AVBP 10-Q: SEC filing

ArriVent BioPharma

Filed with the SEC on · accession 0001104659-26-124513

AVBP filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.

Summary of the filing

ArriVent BioPharma filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures including cash position, equity activity, and license/collaboration agreements.

For details, click here →How to read a 10-Q →

Key details

FilerArriVent BioPharma, Inc.
Collaboration and license agreement counterpartyShanghai Allist Pharmaceuticals Co., Ltd.
License agreement counterpartyLepu Biopharma
Collaboration counterpartyAarvik Pharmaceuticals Inc.
Lender under loan and security agreementSilicon Valley Bank

✦ Ask GOAX AI about this filing — what it means for AVBP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AVBP?

Click here

Frequently asked questions

What did AVBP file with the SEC on Nov 9, 2026?

AVBP filed a 10-Q (SEC filing). ArriVent BioPharma filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures including cash position, equity activity, and license/collaboration agreements.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other AVBP SEC filings

Get alerts when AVBP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
AVBP overviewAVBP analysisAVBP newsLatest SEC filings